Bob Wynalek

Chief Operating & Commercialization Officer, Director at DiscGenics

Mr. Wynalek is a skilled medical device and biologics executive with over 30 years of experience in the orthopedic, spinal and neurosurgical markets. Most recently, Mr. Wynalek was the President of domestic business for Osteotech, Inc. where he oversaw development, regulatory clearance and commercialization of numerous biologic devices for bone healing. Osteotech, Inc. was acquired by Medtronic, Inc. in 2010. Mr. Wynalek currently serves as a committee member of the Alliance for Regenerative Medicine and BioUtah.

Location

Draper, United States

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


DiscGenics

2 followers

DiscGenics is focused on developing regenerative therapies that alleviate pain and restore function in patients with degenerative diseases of the spine.